Evidence map›Paper›PMID 29277016›Full record

ArticleRedox biology2018

Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1.

Dan He, Mingming Zhao, Congying Wu, Wenjing Zhang, Chenguang Niu, Baoqi Yu, Jingru Jin, Liang Ji, Belinda Willard, Anna V Mathew and 6 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. HDL and Therapy.Advances in experimental medicine and biology · 2022
    Article
  19. HDL Mimetic Peptides.Advances in experimental medicine and biology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Dan HeThe Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Health Science Center, Peking University, Beijing 100191, China.
Mingming ZhaoThe Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Health Science Center, Peking University, Beijing 100191, China.
Congying WuThe Institute of Systems Biomedicine, Department of Medical Genetics, Peking University Health Science Center, Beijing 100191, China.
Wenjing ZhangThe Military General Hospital of Beijing, Beijing 100700, China.
Chenguang NiuThe Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Health Science Center, Peking University, Beijing 100191, China.
Baoqi YuThe Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Health Science Center, Peking University, Beijing 100191, China.
Jingru JinThe Military General Hospital of Beijing, Beijing 100700, China.
Liang JiThe Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Health Science Center, Peking University, Beijing 100191, China.
Belinda WillardProteomics Laboratory, Cleveland Clinic, Cleveland, OH 44195, USA.
Anna V MathewDepartment of Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Y Eugene ChenDepartment of Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Subramaniam PennathurDepartment of Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Huiyong YinKey Laboratory of Food Safety Research, Institute for Nutritional Sciences (INS), Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS), Shanghai 200031, China.
Yuan HeNational Research Institute for Health and Family Planning, Beijing 100081, China.
Bing PanThe Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Health Science Center, Peking University, Beijing 100191, China. Electronic address: panbintz@163.com.
Lemin ZhengThe Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Health Science Center, Peking University, Beijing 100191, China. Electronic address: zhengl@bjmu.edu.cn.
Peking University · CNUniversity of Michigan–Ann Arbor · USThe Military General Hospital of Beijing PLA · CNChinese Academy of Sciences · CNCleveland Clinic · US

Funding

University of Michigan O'Brien Kidney Translational Core CenterP30DK081943 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PENNATHUR, SUBRAMANIAM · 2008 to 2022
$12.9M
Myeloperoxidase, Chronic Kidney Disease and AtherosclerosisK08HL130944 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MATHEW, ANNA VACHAPARAMPIL · 2016 to 2021
$893k
NHLBI NIH HHS K08 HL130944NIDDK NIH HHS P30 DK081943
6 · The paper itself

Abstract

Disruption of endothelial monolayer integrity is the primary instigating factor for many cardiovascular diseases. High density lipoprotein (HDL) oxidized by heme enzyme myeloperoxidase (MPO) is dysfunctional in promoting endothelial repair. Apolipoprotein A-1 mimetic 4F with its pleiotropic benefits has been proven effective in many in vivo models. In this study we investigated whether 4F promotes endothelial repair and restores the impaired function of oxidized HDL (Cl/NO

Indexed as

AnimalsAortaCell MovementCell ProliferationEndothelial CellsEndothelium, VascularHumansLipoproteins, HDLMiceNitric OxideNitric Oxide Synthase Type IIIOxidative StressPeptidesPeroxidasePhosphorylationScavenger Receptors, Class Bapolipoprotein A-I mimetic peptide 4FLipoproteins, HDLNitric OxideNitric Oxide Synthase Type IIINOS3 protein, humanPeptidesPeroxidaseScarb1 protein, mouseScavenger Receptors, Class B4FApoA-1Endothelial repairOxidized HDLRe-endothelialization

Identifiers

PMID29277016
PMCPMC5975068
OpenAlexW2771599620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.